FDA Inspection 1204687 — Cosmo S.P.A.

Cosmo S.P.A. — FEI 3004504760

The FDA completed an inspection of Cosmo S.P.A. on Nov 11, 2022 in Lainate. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 11, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lainate (Italy)

Additional details

Mutual Recognition Agreement (MRA)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.